February 3, 2023
Loading...
You are here:  Home  >  'FDA'  -  Page 10
Latest

FDA declines to approve Novartis biosimilar for Amgen’s Neulasta

By   /  Tuesday, July 19th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on FDA declines to approve Novartis biosimilar for Amgen’s Neulasta

The Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining to approve the drug for now. Neulasta, made by Thousand Oaks-based biotech giant Read More →

Latest

Amgen wins one, loses one in biosimilar battle

By   /  Friday, July 15th, 2016  /  East Ventura County, Health Care & Life Science, left, Technology  /  Comments Off on Amgen wins one, loses one in biosimilar battle

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

FDA panel recommends Amgen biosimilar drug for approval

By   /  Tuesday, July 12th, 2016  /  Health Care & Life Science, Latest news, Technology  /  Comments Off on FDA panel recommends Amgen biosimilar drug for approval

A Food and Drug Administration panel recommended an Amgen biosimilar drug for approval July 12, just days after it said the biosimilar performed like a drug it mimicked. ABP 501, made by Thousand Oaks biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and Read More →

Latest

FDA OKs wearable injector for Amgen’s Repatha cholesterol drug

By   /  Monday, July 11th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on FDA OKs wearable injector for Amgen’s Repatha cholesterol drug

The U.S. Food and Drug Administration approved a new type of injector for Amgen’s cholesterol reducing drug Repatha on July 11. The FDA approved a wearable injector, called the “Pushtronex” system, that sticks to patients’ bodies and delivers a dose of the drug monthly under the skin. Patients can perform moderate physical activities like walking Read More →

Latest

FDA finds Amgen biosimilar replicates effects of Humira

By   /  Friday, July 8th, 2016  /  Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on FDA finds Amgen biosimilar replicates effects of Humira

The Food and Drug Administration said a new Amgen biosimilar replicates the effects of a competitor’s blockbuster drug July 8. ABP 501 replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and colon inflammation. The drug, made by Chicago-based competitor AbbVie, typically costs $20,000 per year for Read More →

Latest

Amid losses, Sientra makes an acquisition

By   /  Friday, March 11th, 2016  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amid losses, Sientra makes an acquisition

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Sientra implants back on market

By   /  Friday, February 12th, 2016  /  Health Care & Life Science, middle, Technology  /  Comments Off on Sientra implants back on market

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.